Advertisement
Berita Valas
Asian Markets Mixed Amid Lack Of Cues
Asian stock markets are trading mixed on a subdued note on Tuesday, following the mixed cues from global markets ahead of them closing for a long Christmas holiday weekend, as traders remain cautious and do not want to hold on to any significant positions during the holiday ridden final week of the year. Asian markets closed mixed on Monday.
RTTNews |
581 days ago
Sensex, Nifty To Open On Flat Note Amid Muted Global Cues
Indian shares look set to open on a flat note Tuesday as markets head into the final week of 2023. Volatility may increase this week due to the scheduled expiry of December month derivative contracts.
RTTNews
|
581 days ago
Japanese Market Slightly Lower
Giving up some of the gains the previous two sessions, the Japanese stock market is slightly lower on Tuesday, with the Nikkei 225 staying above the 33,200 mark, following the lack of any major cues from global markets overnight as they were closed for Christmas holiday.
RTTNews
|
581 days ago
Australian Dollar Falls Against Majors
The Australian dollar weakened against other major currencies in the Asian session on Monday.
RTTNews
|
582 days ago
TSX Ends On Firm Note Ahead Of Holidays
The Canadian market ended on a firm note on Friday ahead of a long weekend, with stocks from healthcare, real estate and consumer staples sectors finding strong support.
RTTNews
|
584 days ago
Dollar Loses Ground Against Major Rivals As PCE Data Raises Rate Cut Prospects
The U.S. dollar shed its value against its major counterparts on Friday after data showing a slower than expected increase in the Federal Reserve's preferred measure of inflation raise hopes the central bank will start cutting interest rates early next year.
RTTNews
|
584 days ago
Swiss Market Ends Marginally Up As Stocks Move Up In Final Hour
Despite spending much of the day's session in negative territory, the Switzerland market ended marginally up on Friday thanks to some brisk buying at select counters in the final hour.
RTTNews
|
584 days ago
more news
European Stocks Close Slightly Higher After Cautious Session
European stocks closed slightly higher on Friday with investors assessing the likely move of the Federal Reserve following the latest data on consumer price growth, digesting the data from the European region, and monitoring the developments around the Red Sea.
RTTNews
|
584 days ago
U.S. Dollar Down As Soft Inflation Data Supports Rate Cut Hopes
The U.S. dollar was lower against its major counterparts in the New York session on Friday, as the Federal Reserve's preferred measure of inflation slowed more than expected in November, reinforcing expectations that the Federal Reserve will begin cutting interest rates in March.
RTTNews
|
584 days ago
Canadian Market Up Firmly In Positive Territory; Materials Shares Rise
The Canadian market is up in positive territory around late morning on Friday, supported by gains in healthcare, materials and real estate sectors.
RTTNews
|
584 days ago
U.S. Consumer Sentiment Improves More Than Previously Estimated In December
Revised data released by the University of Michigan on Friday showed consumer sentiment in the U.S. improved by slightly more than initially estimated in the month of December. The University of Michigan said its consumer sentiment index for December was upwardly revised to 69.7 from a preliminary reading of 69.4. Economists had expected the index to be unrevised.
RTTNews
|
584 days ago
U.S. New Home Sales Unexpectedly Plunge To One-Year Low In November
New home sales in the U.S. unexpectedly saw a substantial decrease in the month of November, according to a report released by the Commerce Department on Friday. The report said new home sales plummeted by 12.2 percent to an annual rate of 590,000 in November after tumbling by 4.0 percent to a revised rate of 672,000 in October.
RTTNews
|
584 days ago
Merck, Daiichi Sankyo Say FDA Grants Priority Review In U.S. For Patritumab Deruxtecan
Merck & Co. Inc. (MRK) and Japan's Daiichi Sankyo Co. Ltd. (DSKYF.PK) announced Friday that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the Biologics License Application (BLA) for patritumab deruxtecan (HER3-DXd) for the treatment of adult patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC) previously treated with two or more systemic therapies.
RTTNews
|
584 days ago
Stay up to date!
Add Berita to your browser
Add To Chrome
